Paper · 36459568
Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity.
Williams HL and 38 others. Cancer Res, 2023. Cited by 95 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity. Papers, record 36459568. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36459568
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pancreatic Neoplasms | Major topic |
| Carcinoma, Pancreatic Ductal | Major topic |
| Humans | |
| Prognosis | |
| Phenotype | |
| RNA | |
| Gene Expression Regulation, Neoplastic | |
| Claudins |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R35 CA197735 | NCI NIH HHS | United States | R35CA197735 | PubMed | NIH RePORTER |
| U01 CA210171 | NCI NIH HHS | United States | U01CA210171 | PubMed and NIH | NIH RePORTER |
| R01 CA248857 | NCI NIH HHS | United States | R01CA248857 | PubMed | NIH RePORTER |
| P30 ES001247 | NIEHS NIH HHS | United States | P30ES001247 | PubMed | NIH RePORTER |
| R01 CA276268 | NCI NIH HHS | United States | R01CA276268 | PubMed and NIH | NIH RePORTER |
| R01 CA205406 | NCI NIH HHS | United States | R01CA205406 | PubMed | NIH RePORTER |
| R01 CA169141 | NCI NIH HHS | United States | R01CA169141 | PubMed | NIH RePORTER |
| U01 CA250549 | NCI NIH HHS | United States | U01CA250549 | PubMed and NIH | NIH RePORTER |
| P50 CA127003 | NCI NIH HHS | United States | P50CA127003 | PubMed | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34,644,529 | Spatially confined sub-tumor microenvironments in pancreatic cancer. | Cell | 2021 | https://conductscience.org/library/papers/34644529 | PubMed |
| 2 | 32,629,389 | Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer. | EBioMedicine | 2020 | https://conductscience.org/library/papers/32629389 | PubMed |
| 3 | 31,375,762 | Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer. | Sci Rep | 2019 | https://conductscience.org/library/papers/31375762 | PubMed |
| 4 | 31,395,068 | Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. | Radiat Oncol | 2019 | https://conductscience.org/library/papers/31395068 | PubMed |
| 5 | 29,903,880 | Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine. | Cancer Discov | 2018 | https://conductscience.org/library/papers/29903880 | PubMed |
| 6 | 26,343,385 | Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. | Nat Genet | 2015 | https://conductscience.org/library/papers/26343385 | PubMed |
| 7 | 33,324,659 | Keratin 17 Suppresses Cell Proliferation and Epithelial-Mesenchymal Transition in Pancreatic Cancer. | Front Med (Lausanne) | 2020 | https://conductscience.org/library/papers/33324659 | PubMed |
| 8 | 33,262,135 | Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer. | Clin Cancer Res | 2021 | https://conductscience.org/library/papers/33262135 | PubMed |
| 9 | 25,488,926 | Updated UK Recommendations for HER2 assessment in breast cancer. | J Clin Pathol | 2015 | https://conductscience.org/library/papers/25488926 | PubMed |
| 10 | 31,201,285 | Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome. | Gut | 2020 | https://conductscience.org/library/papers/31201285 | PubMed |
1 to 10 of 31
See all 31 referencesCited by70
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,876,041 | Basal Marker ΔNp63α Is Enriched in Pancreatic Cancer Metastases but Not in Primary Tumors Post-Chemotherapy. | Cancer Med | 2026 | https://conductscience.org/library/papers/42876041 | PubMed |
| 42,738,256 | The Classical-Basal Spectrum in Pancreatic Ductal Adenocarcinoma: A Developmental Framework for Tumour Cell Plasticity and Clinical Translation. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738256 | PubMed |
| 42,649,389 | Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic dependencies in pancreatic cancer. | Nat Genet | 2026 | https://conductscience.org/library/papers/42649389 | PubMed |
| 42,649,211 | Oncogenic Kras targeting with MRTX1133 or Daraxonrasib specifically synergize with anti-CTLA4 to promote anti-tumor immunity in pancreatic cancer. | Nat Commun | 2026 | https://conductscience.org/library/papers/42649211 | PubMed |
| 42,632,864 | Dual-oxygen pancreatic cancer organoids recapitulate basal-classical heterogeneity validated by spatial transcriptomics. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42632864 | PubMed |
| 42,523,238 | The basal cell state maintains pancreatic cancers by controlling an immunosuppressive circuit. | bioRxiv | 2026 | https://conductscience.org/library/papers/42523238 | PubMed |
| 42,476,970 | LSD1-GLS2 axis drives subtype-specific chemoresistance in pancreatic cancer through glutaminolysis reprogramming. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42476970 | PubMed |
| 42,439,673 | Spatial-Niche Perspective on the Heterogeneity and Functional Reprogramming of Tumor-Associated Macrophages in Digestive System Tumors. | Cells | 2026 | https://conductscience.org/library/papers/42439673 | PubMed |
| 42,346,787 | Barettin Suppresses Pancreatic Ductal Adenocarcinoma Proliferation via Topoisomerase IIα Inhibition. | Mar Drugs | 2026 | https://conductscience.org/library/papers/42346787 | PubMed |
| 42,225,812 | Rapid autofluorescence based 3D optical imaging of the pancreatic cancer milieu at mesoscopic scale - stain-free volumetric segmentation. | Sci Rep | 2026 | https://conductscience.org/library/papers/42225812 | PubMed |
1 to 10 of 70
See all 70 cited byGenes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDKN2A | 1,029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| CLDN18 | 51,208 | PubTator's text mining | https://conductscience.org/library/genes/51208 | NCBI Gene |
| GATA6 | 2,627 | PubTator's text mining | https://conductscience.org/library/genes/2627 | NCBI Gene |
| KRAS | 3,845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| KRT17 | 3,872 | PubTator's text mining | https://conductscience.org/library/genes/3872 | NCBI Gene |
| KRT5 | 3,852 | PubTator's text mining | https://conductscience.org/library/genes/3852 | NCBI Gene |
| S100A2 | 6,273 | PubTator's text mining | https://conductscience.org/library/genes/6273 | NCBI Gene |
| SMAD4 | 4,089 | PubTator's text mining | https://conductscience.org/library/genes/4089 | NCBI Gene |
| TFF1 | 7,031 | PubTator's text mining | https://conductscience.org/library/genes/7031 | NCBI Gene |
| TP53 | 7,157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
1 to 10 of 11
See all 11 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36459568
GET https://conductscience.org/api/papers/v1/36459568/authors?page=2